Pfizer picks up Brazil's Teuto in $240M deal

Pfizer will pay $240 million for a 40 percent stake in Brazil's Laboratorio Teuto Brasileiro, a generics specialist, as it expands further in emerging markets. Report

Suggested Articles

Manufacturing

Zantac, similar OTC meds found to contain suspected carcinogen

A suspected cancer-causing impurity that has been found in some blood pressure medicines has now shown up in Zantac and some OTC antacids.

by Eric Palmer
Stockholm, Sweden
Pharma

Roche's Ocrevus, given early, cuts wheelchair risk by 42%: study

Roche is steamrolling with Ocrevus, and to maintain that lead, its touting long-term data that show the earlier it’s given, the better patients do.

by Carly Helfand
Novartis
Pharma

Novartis' reinvented leukemia drug bests Sanofi's Aubagio in MS

New data shows a significant reduction in relapse rates in patients taking Novartis' repurposed cancer drug ofatumumab.

by Arlene Weintraub